HTLV-1 infects approximately 5–10 million people worldwide mainly in subtropical areas [1].
In the vast majority of cases, HTLV-1 infection remains clinically silent. Among asymptomatic …

Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus that causes cancer (Adult T cell
Leukemia, ATL) and a spectrum of inflammatory diseases (mainly HTLV-associated …

Human T-cell leukemia/lymphoma virus type 1 (HTLV-1), a member of the delta-retrovirus
family, is an oncogenic retrovirus that is etiologically associated with adult T-cell leukemia …

Human T cell leukemia virus type 1 (HTLV-1), also known as human T lymphotropic virus
type 1, was the first exogenous human retrovirus discovered. Unlike the distantly related …

Human T-cell leukemia virus type 1 (HTLV-1) is a replication-competent human retrovirus
associated with two distinct types of diseases: a malignancy of mature CD4+ T cells called …

HTLV-1 is an oncogenic human retrovirus associated with several diseases including adult
T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic …

It has been three decades since the discovery of human T-cell leukemia virus type 1 (HTLV-
1), which is the first human retrovirus etiologically associated with an aggressive malignancy …

Human T-Lymphotropic virus type 1 (HTLV-1) is the causative agent of two distinct
pathologies, adult T-cell leukemia (ATL), an aggressive malignancy of mature CD4+ T-cells …

Human T‐cell leukemia virus type 1 (HTLV‐1) was discovered in the 1980s, but it is
estimated to have been infecting humans for more than ten thousand years. 1 With over 90 …

Human T-cell leukemia virus type 1 (HTLV-1) was the first human retrovirus discovered.
Studies on HTLV-1 have been instrumental for our understanding of the molecular …